Ireland-based manufacturer of private label over-the-counter pharmaceuticals Perrigo Company plc (NYSE: PRGO) announced its quarterly dividend on Thursday.
The company has declared dividend of USD0.276 per share.
The dividend will be paid to shareholders of record at 30 August 2024 on 17 September 2024.
Amgen announces Q3 2024 dividend
Perrigo announces quarterly dividend
Valneva receives CEPI funding to boost access to world's first chikungunya vaccine
Emmaus Life Sciences reports 2023 financial results
Quest Diagnostics to acquire LifeLabs from OMERS for USD1.35bn
Eli Lilly announces Q3 2024 dividend
Valneva's chikungunya vaccine IXCHIQ approved by Health Canada